Background-Right ventricular failure from increased pulmonary vascular loading is a major cause of morbidity and mortality, yet its modulation by disease remains poorly understood. We tested the hypotheses that, unlike the systemic circulation, pulmonary vascular resistance (R PA ) and compliance (C PA ) are consistently and inversely related regardless of age, pulmonary hypertension, or interstitial fibrosis and that this relation may be changed by elevated pulmonary capillary wedge pressure, augmenting right ventricular pulsatile load. Methods and Results-Several large clinical databases with right heart/pulmonary catheterization data were analyzed to determine the R PA -C PA relationship with pulmonary hypertension, pulmonary fibrosis, patient age, and varying pulmonary capillary wedge pressure. Patients with suspected or documented pulmonary hypertension (nϭ1009) and normal pulmonary capillary wedge pressure displayed a consistent R PA -C PA hyperbolic (inverse) dependence, C PA ϭ0.564/(0.047ϩR PA ), with a near-constant resistance-compliance product (0.48Ϯ0.17 seconds). In the same patients, the systemic resistance-compliance product was highly variable. Severe pulmonary fibrosis (nϭ89) did not change the R PA -C PA relation. Increasing patient age led to a very small but statistically significant change in the relation. However, elevation of the pulmonary capillary wedge pressure (nϭ8142) had a larger impact, significantly lowering C PA for any R PA and negatively correlating with the resistance-compliance product (PϽ0.0001). Conclusions-Pulmonary hypertension and pulmonary fibrosis do not significantly change the hyperbolic dependence between R PA and C PA , and patient age has only minimal effects. This fixed relationship helps explain the difficulty of reducing total right ventricular afterload by therapies that have a modest impact on mean R PA . Higher pulmonary capillary wedge pressure appears to enhance net right ventricular afterload by elevating pulsatile, relative to resistive, load and may contribute to right ventricular dysfunction. (Circulation. 2012;125:289-297.)
W
hen the left side of the heart ejects blood into the systemic arteries, it must overcome both a mean resistive load, regulated by small peripheral vessels, and a pulsatile load related mostly to proximal aortic compliance. This geographic distribution of different vessels dominating resistive versus capacitive properties is important in understanding how the load of the left side of the heart varies with aging and disease. With aging, aortic stiffening and faster flow transmission to the periphery (enhancing wave reflection) result in systolic hypertension with less change in resistance. [1] [2] [3] Increases in resistance with resulting elevation of mean pressure also reduce overall arterial compliance (eg, essential hypertension in a young patient), although not as much as with primary stiffening of the thoracic aorta.
Clinical Perspective on p 297
The pulmonary circulation is very different, although this disparity has been highlighted only recently as pulmonary hypertension (PH) and disease of the right side of the heart are attracting more attention. In a series of relatively small studies involving patients with and without PH, the VonkNoordegraaf laboratory showed that mean pulmonary vascular resistance (R PA ) and pulmonary arterial compliance (C PA ) are consistently inversely related. 4 -6 More recently, Bonderman et al 7 reported similar findings in patients after pulmonary endarterectomy. As a consequence, the product of resistance and compliance (RC time) is nearly constant, and C PA can be predicted with knowledge of R PA . This means that the vessels responsible for pulmonary resistance and compliance are more or less the same (eg, distal) and that this geographic distribution is unaltered by PH. The generalizability of these findings to other patient types, including patients with abnormal left ventricular function, at different ages, or under conditions of acute hemodynamic stress, is unknown. We performed a retrospective analysis of pulmonary (and systemic) arterial hemodynamics from several large patient populations to robustly test the R PA -C PA dependence and to determine its sensitivity to pulmonary fibrosis, patient age, and pulmonary venous capillary wedge pressure (PCWP). Unlike the situation in systemic arteries, we found a hyperbolic R PA -C PA dependence for lung that varies minimally with the cause of PH (excluding World Health Organization group II PH), with severe interstitial fibrosis, or with patient age. We also found that PCWP has a significant effect on this dependence, resulting in a higher right ventricular (RV) pulsatile load.
Methods

Clinical Data Sets and Patient Populations
For the Johns Hopkins cohort, the Institutional Review Board approved retrospective access to deidentified patient data under a HIPAA waiver. The Mayo Clinic and Columbia University Institutional Review Boards approved the prospective data collection for all individuals included in this analysis, and signed consents were obtained. The hemodynamic data required for each patient analysis were mean cardiac output (thermodilution or Fick based); right atrial, mean, systolic, and diastolic pulmonary arterial and/or systemic arterial pressures; and heart rate. In addition, we obtained demographic information and primary cardiac or pulmonary disease diagnosis. Data were examined from 4 different databases.
Cohort A: Suspected or Known PH
The Johns Hopkins Hospital Cardiac Catheterization Database was queried to identify all patients receiving an isolated right heart catheterization (RHC) for suspected (SPH) or known PH between 2000 and 2010. Patients receiving an RHC at the time of left heart catheterization or coronary angiogram were excluded. All RHC procedures and subsequent waveform analysis in this database were performed by a clinical cardiologist who specializes in heart failure. Pressures are reported at end expiration. All patients found to have a PCWP Ͼ15 mm Hg (ie, World Health Organization group II PH) were also excluded from this analysis. A total of 1009 patients with a PCWP Յ15 mm Hg were identified with adequate hemodynamic data. This cohort included patients with World Health Organization group I, III, IV, and V PH.
Cohort B: Interstitial Lung Disease
We queried the New York Presbyterian Interstitial Lung Disease Program database at Columbia University, identifying 86 patients with idiopathic pulmonary fibrosis and 3 patients with fibrosis resulting from chronic eosinophilic pneumonia who had complete hemodynamic data and PCWP Յ15 mm Hg. PCWP tracings were independently interpreted by 2 pulmonologists, and differences were decided by consensus. Pressures are reported at end expiration. Patients were enrolled between February 2007 and April 2011. RHC was performed for SPH or as a routine component of lung transplant evaluation. Carbon monoxide diffusion capacity analysis was obtained in 95% of the patients, all of whom had carbon monoxide diffusion capacity Ͻ41% of predicted.
Cohort C: General RHC Analysis
The Johns Hopkins Hospital Cardiac Catheterization Database was queried for all patients receiving an isolated RHC between 2000 and 2010 for any indication, yielding 8463 patients. Data collection and analysis were performed as in cohort A, and all patients in cohort A were included in cohort C. Of these, 8142 had adequate hemodynamic data sets. A subgroup of cohort C (nϭ207) was identified with a diagnosis of heart failure and at least 2 clinical cardiac catheterizations at distinct time points: at PCWP Յ10 mm Hg and at PCWP Ն20 mm Hg. Multiple catheterizations were done either for ongoing management of heart failure or as part of a cardiac transplantation/ left ventricular assist device evaluation or posttransplantation/left ventricular assist device follow-up.
Cohort D: Early-Stage Heart Failure With Preserved Ejection Fraction
Rest and supine exercise hemodynamic data from 24 patients with early-stage heart failure with preserved ejection fraction were obtained at the Mayo Clinic. All RHC procedures and subsequent waveform analysis in this database were performed by a clinical cardiologist specializing in heart failure. Patients were classified as having early-stage heart failure with preserved ejection fraction if their resting PCWP was Յ15 mm Hg and peak exercise PCWP was Ն25 mm Hg. Resting and exercise pressures were reported at end expiration. A detailed description of this protocol has previously been published. 8 To further test the reliability of the PCWP recordings from the clinical database, we randomly selected 50 patients from cohort C and 10 from cohort B, had the tracings reviewed blinded to patient by 2 cardiologists (RJT, OHC), averaged their values, and then compared them with the recorded clinical entry using Bland-Altman analysis ( Figure I in the online-only Data Supplement). The results show excellent agreement (95% limits of agreement, Ϫ5.9 to 2.6 mm Hg), with slight underestimation (Ϫ1.7 mm Hg) in the clinical recorded database.
Calculations of Resistance, Compliance, and RC Time
R PA is calculated mean pulmonary artery [PA] pressure minus PCWP divided by cardiac output, expressed as mm Hg ⅐ s ⅐ mL Ϫ1 . C PA is estimated by stroke volume divided by PA pulse pressure (mL ⅐ mm Hg Ϫ1 ), as validated by several studies. 1,4,9 Systemic arterial resistance (R SA ) is calculated as mean systemic arterial pressure minus mean right atrial pressure divided by cardiac output. Systemic arterial compliance (C SA ) is determined from stroke volume divided by systemic arterial pulse pressure. The RC time (product of resistance and compliance) is therefore expressed as units of seconds.
Statistics
Data are presented as meanϮSD. Curve fits (linear or nonlinear) were generated and statistical analysis was performed with SigmaPlot version 11.0/Systat version 10.2. SigmaPlot uses the MarquardtLevenberg algorithm for nonlinear regression curve fits. Comparison of various patient cohorts was performed with either the unpaired Student t test or the Mann-Whitney rank-sum test as appropriate or, for multiple groups, by 1-way ANOVA or ANOVA on ranks. The Holm-Sidak or Dunn method was used for post hoc multiple comparisons. The Pearson 2 test was performed for 2-way cross-tabulation. An F test was used to compare variances of pulmonary and systemic RC times. Other analyses such as multiple linear regressions are indicated when appropriate. A value of PϽ0.05 was considered statistically significant.
Results
R PA -C PA Dependence in Patients With SPH/PH
Demographic and hemodynamic data for all cohorts are summarized in the Table. Figure 1A displays the scatterplot of R PA versus C PA from the 1009 patients in cohort A. There was a consistent inverse dependence fit by the first-order (with offset) hyperbolic decay (r 2 ϭ0.74): R PA ϭ0.564/ (0.047ϩC PA ). In contrast, a similar plot of systemic arterial R SA versus C SA ( Figure 1B , shown with curve fit to PA data) showed greater dispersion (r 2 ϭ0.46). The inverse dependence between R PA and C PA was not dictated by their sharing of stroke volume in the numerator of one and denominator of the other. Removing stroke volume from C PA (ie, 1/PA pulse pressure) and cardiac output from R PA (PA mean ϪPCWP) yielded a similar relation ( Figure IIA in the online-only Data Supplement). Reintroducing heart rate into the latter also did not alter the relation (not shown). To better quantify the disparity between circulations, RC time was plotted versus mean pressure for each respective vascular bed ( Figure 1C ). The RC time was narrowly constrained in the pulmonary system (mean, 0.48Ϯ0.17 seconds) but was highly variable in the systemic arteries for any mean pressure (varianceϭ0.027 versus 0.163; PϽ10 Ϫ5 ). Lastly, we tested whether the R PA -C PA dependence was changed by lung interstitial stiffness in cohort B, comprising patients with severe pulmonary fibrosis. A nearly identical dependence was observed ( Figure 1D 
Age and the Pulmonary ResistanceCompliance Relation
We next evenly divided the 1009 SPH/PH subjects into age tertiles to test the impact of patient age. Figure 2A highlights the very different effects of patient age on the pulmonary versus systemic vasculature. In the pulmonary plot, the distribution of patients in each age tertile was scattered throughout the hyperbola, whereas the data were clustered for the systemic circulation, with the oldest tertile dominating the lower right region and the youngest tertile dominating the upper left region. Figure 2B depicts this in graphic form, showing the percentage of patients within each age tertile who lay within each compliance or resistance tertile for the 2 circulations. In the systemic circulation, there was a marked age-dependent shift from higher to lower compliance and 
Race, n (%) SPH indicates suspected pulmonary hypertension; PH, pulmonary hypertension; ILD, interstitial lung disease; RHC, right heart catheterization; PCWP, pulmonary capillary wedge pressure; HFpEF, heart failure with preserved ejection fraction; and PAP, pulmonary arterial pressure. Values are meanϮSD when appropriate.
lower to higher resistance (both PϽ0.00001; P values are for 2 2-way cross-tabulation). The distribution was more even among age groups for the pulmonary data, and older patients were more prevalent in the high compliance tertile. As a result, the impact of patient age on the pulmonary R PA -C PA relation was small though still statistically significant. This was formally tested by log transformation of each curve and subsequent ANCOVA with age used as a categorical (and continuous) variable (PϽ0.001; Figure III in the online-only Data Supplement). For a median R PA of 3 Wood units, C PA fell from 2.64 to 2.15 mL ⅐ mm Hg Ϫ1 as age rose from 20 to 90 years, or a 19% decline over 70 years. Figure 3A displays the R PA -C PA relationship from the 8142 patients in cohort C. The curve fit based on the PH/SPH population is reproduced for comparison. Unlike cohorts A and B, in whom PCWP was in the normal range, the broader patient group had many subjects with reduced C PA for a given R PA . This change depended on PCWP; those patients with a PCWP Յ10 mm Hg (black) lay on the previously derived curve, whereas those with PCWP Ն20 mm Hg had a disproportionate decline in C PA (red). We again confirmed that this change was not driven by stroke volume ( Figure IVA in the online-only Data Supplement). Converting the data to a log (R PA )-log (C PA ) plot ( Figure 3B) showed that the impact of PCWP was continuous with a downward-leftward shift in the relation with higher PCWP. The magnitude of the shift was much greater than that observed by age. For example, at a given R PA of 3 Wood unit, C PA is lowered from 3.34 to 1.65 to 0.82 mL ⅐ mm Hg Ϫ1 as PCWP increases from 0 to 25 to 50 mm Hg, respectively (C PA range, 2.52 mL ⅐ mm Hg Ϫ1 ). Increased PCWP therefore also resulted in a lower RC time, principally as a result of lower compliance (RCϭ Ϫ0.0063ϫPCWPϩ0.46; Figure 3C ; r 2 ϭ0.98; PϽ0.002). This is also displayed in plots of RC versus mean pressure ( Figure IVB in the online-only Data Supplement). The magnitude of RC decline was much greater than that observed with patient age.
Increasing PCWP and the Pulmonary Resistance-Compliance Relation
To further test the impact of PCWP on the R PA -C PA dependence, we examined a subgroup of cohort C (nϭ207) who had a diagnosis of heart failure and 2 RHCs at different time points: when PCWP was Յ10 mm Hg and when PCWP 047ϩx) . B, Systemic arterial resistance-compliance (R SA -C SA ) relationship for the same patient cohort, with the curve fit for pulmonary data also shown. C, Resistance-compliance product for pulmonary or systemic vasculature plot vs mean artery pressure. D, R PA -C PA relationship in patients with severe pulmonary fibrosis. The best-fit hyperbolic decay for these patients (dotted) is compared with the cohort A result (gray solid line); they were identical.
Ն20 mm Hg. We also examined 24 patients (Cohort D) with early-stage heart failure with preserved ejection fraction, meaning a PCWP Յ15 mm Hg at rest, but in whom PCWP rose Ն25 mmHg during supine exercise. As shown in Figure  4A may enhance the pulsatile relative to resistive load on the right heart.
Discussion
After nearly half a century, there has been broad acceptance that the systemic arterial circulation combines a resistive and capacitive load and that these can vary at least partially independently of one another. The pulmonary vasculature is very different, coupling resistance and compliance in a very constrained manner as long as pulmonary venous pressure is low. Increasing PCWP appears to alter this behavior to augment right heart pulsatile load. The present study establishes key properties for right heart-pulmonary vascular coupling and illustrates a previously unappreciated deleterious impact of left heart pressures on pulsatile RV load. This is important because RV dysfunction is a major independent predictor of death resulting from cardiac and/or pulmonary vascular disease. 10 -13 It has previously been shown that the R PA -C PA relation does not change with treatment of PH. 5 The consistency and shape of the R PA -C PA relation, which our study confirms in large patient groups with normal-range PCWP, have important clinical implications. The overall predictability of the relationship means that a simple set of RHC data defines a given patient's position on a shared continuum curve, allowing one to possibly predict a therapeutic target. From this relation, clinicians may be able to estimate how much R PA must be lowered to have any meaningful change in C PA and thus pulsatile (and net) afterload. It also indicates that unlike the proximal aorta in the systemic circulation, the main PA Figure 3 . Effect of elevated pulmonary capillary wedge pressure (PCWP) on pulmonary vascular resistance-compliance relationship (R PA -C PA ). A, R PA -C PA relationship from 2 subgroups of cohort C, those with normal-range or elevated PCWP. Gray line is the best-fit curve from Figure 1A (cohort A) . B, Log(R PA )-log(C PA ) plot (nϭ4735), color coded into 5 subgroups based on PCWP (PϽ0.001) C, Mean resistance-compliance product (RC time) for each PCWP subgroup vs PCWP. SPH/PH indicates suspected/known pulmonary hypertension.
adds relatively little to overall pulmonary vascular compliance because, if the PA stiffened independently of resistance with PH, the RC time would decline. This is further supported by work of Saouti et al, 6 who determined that proximal pulmonary arteries contribute only 19% to overall compliance and that, unlike systemic arteries, pulmonary vascular compliance is distributed evenly throughout the peripheral lung in conjunction with resistance. Small age-dependent changes in C PA also support this notion and are consistent with little rise in pulse-wave velocity from the main PA to the peripheral lung with aging. 14 Although some change in main PA distensibility can occur with disease or age, it is small and has less impact on RV load than what is determined by the peripheral vessels. The flatness of the curve at elevated R PA means that resistance must decline substantially to affect net RV loading meaningfully because pulmonary compliance would still be quite low. This was first suggested by Lankhaar et al 4 and may underscore why hemodynamic measurements, including R PA , have been generally unreliable end points for clinical PH management. 15 One can appreciate this problem by plotting the average pretreatment and posttreatment R PA from 3 large therapeutic PH trials involving sildenafil, treprostinil, and prostacyclin, respectively ( Figure 5 ). 16 -18 A high baseline R PA (0.62, 0.77, and 0.96 mm Hg ⅐ s ⅐ mL Ϫ1 , respectively) and modest decline with treatment (0.50, 0.71, and 0.63 mm Hg ⅐ s ⅐ mL Ϫ1 , respectively) would mean little to no change in estimated compliance, thus maintaining a high RV pulsatile load. Although these therapies are used clinically, more effective treatment would need to reduce R PA further or differentially enhance C PA to also affect pulsatile load.
The sensitivity of R PA -C PA relation to pulmonary venous pressure introduces a new way of considering the hemodynamic consequences of elevated left-sided filling pressures. We initially considered that a high PCWP might affect parenchymal stiffness, with the lung acting more like a wet sponge than a dry sponge. Distensibility of small vessels in the lung tissue is enhanced when surrounded by compressible air, but this would be diminished if the parenchyma stiffened. One counter to this theory is the data showing that severe pulmonary fibrosis does not generate the same effect. An alternative is that PCWP is the downstream pressure that amplifies a peripheral pulse reflection, thereby augmenting systolic pulmonary arterial pressure (PAP) and leading to a decline in total compliance.
The impact of PCWP on pulmonary arterial and thus right heart loading is likely relevant to clinical symptoms in heart failure patients. Such individuals become dyspneic during exercise when PCWP frequently rises. Lewis et al 19 recently Figure 4 . Effect of pulmonary vascular resistance-compliance relationship (R PA -C PA ) relationship by change in pulmonary capillary wedge pressure (PCWP) within an individual patient. A, R PA -C PA for each patient is plotted at 2 different study times: at a low PCWP (PCWP Յ10 mm Hg) and at a high PCWP (PCWP Ն20 mm Hg). B, Effect of increasing PCWP during supine exercise on R PA -C PA in 24 patients with early heart failure with preserved ejection fraction. is shown, and superimposed on it are mean pretreatment and posttreatment R PA derived from 3 PH therapeutic trials involving sildenafil, treprostinil, and prostacyclin, respectively. 16 -18 There were high resting R PA and low C PA and only a modest decline in R PA with treatment; therefore, C PA remained low and thus pulsatile load remained high after therapy.
showed that symptoms and clinical outcomes of patients with left ventricular dysfunction correlate better with augmentation in PAP than the change in PCWP. At first glance, this may seem to be in contrast to the findings in this study. However, we would suggest that this observation could be explained by the effect of PCWP on the R PA -C PA relationship. Elevations in PCWP lower C PA for a given R PA , resulting in enhanced pulmonary arterial wave reflections and augmentation of the systolic PAP and thus mean PAP. Therefore, the higher proportional rise in mean PAP compared with PCWP could be explained by the indirect effect of rising PCWP lowering C PA . Our findings also indicate that with the rise in PCWP, there will be enhanced pulsatile RV load, which would further limit RV ejection and in turn left ventricular filling. Indeed, in the patients in whom mean PAP augmentation plateaued during exercise (indicating RV dysfunction), prognosis was worse.
Our study has several limitations. We relied on the recorded clinical indication for RHC for identifying patients with SPH or known PH, and although the actual diagnosis was more mixed and indeed some did not have PH, the consistency of the R PA -C PA relation despite this further supports the idea of its constancy as long as PCWP is in the normal range. Similarly, for all cohorts, we relied on the original operator's recordings and interpretation of hemodynamic data. It is possible that interpretations of tracings may have been different among individual operators. However, the primary data were all interpreted by heart failure cardiologists or pulmonologists, and our blinded review found minimal interobserver error on a random subset of studies. Lastly, we relied on an indirect estimate of total pulmonary vascular compliance. Alternative approaches using pulsatile pressure-flow analysis are difficult and impractical for large population studies, but the estimation method has compared favorably with such alternative approaches in smaller controlled studies. [1] [2] [3] [4] 
Conclusions
The pulmonary circulation and the afterload it imposes on the RV are very different from the systemic circulation. PH, interstitial fibrosis, and patient age do not appear to have much effect on the inverse, hyperbolic R PA -C PA relationship. Because of the consistency of this relationship, one can estimate pulmonary vascular compliance from resistance using a simple equation, identify where a given patient lies relative to normal, and possibly anticipate what therapy would need to achieve for a robust clinical benefit. The findings that a higher PCWP may affect pulmonary arterial and thus RV pulsatile loading offer new insight into the symptomatology of heart failure with preserved ejection fraction and other left heart failure disorders.
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